Reports
Reports
Sale
The endometrial ablation market size was valued at USD 3.4 billion in 2022, driven by the incidence of gynaecological disorders such as menorrhagia and PCOS across the globe. The market is expected to grow at a CAGR of 6% during the forecast period of 2023-2031, with the values likely to rise from USD 3.6 billion in 2023 to USD 5.7 billion by 2031.
Endometrial ablation is the procedure of removing the innermost lining (endometrium) of the uterus. It is done to reduce the heavy flow of blood during menstruation, mostly in menopausal or post-menopausal women or in women with fibroids, polyps, uterine or endometrial cancer. Endometrial ablation is a non-surgical procedure, where the healthcare provider may use a slender tool to enter the uterus via vaginal opening, without making any incision.
They may use electric current, fluids (hydrothermal), balloon therapy, high energy radio waves, or the cold temperature as a type of the procedure. Women going through endometrial ablation may not be able to get pregnant as the procedure destroys the lining where the eggs implant itself post-fertilisation.
Menorrhagia is common issue in women, affecting approximately 30% of the population in their reproductive age. Therefore, the endometrial ablation market value has seen a significant boost during the historic period, as it is a common treatment for menorrhagia. Endometrial ablation techniques can be divided into two broad categories, resectoscope and non-resectoscope.
Resectoscopic endometrial ablation is performed under hysteroscopic guidance using a rollerball, monopolar, or bipolar loop electrode. It uses thermal energy to desiccate the endometrial lining, up to the level of the basalis layer. However, operator expertise and safety has been a major area of concern in resectoscopic endometrial ablation. Hence, over the years, the preference has shifted towards second-generation techniques, which are based on using thermal fluid, microwave or bipolar radiofrequency electrical energy, laser thermotherapy, and cryoablation. These options have become eminent, owing to the ease of accessibility, safety, and similar precision to resectoscopic techniques.
As patient-centred care holds utmost importance in the management of heavy menstrual bleeding, the scientists have been working towards developing a more personalised ablation for each patient. For instance, a US based medical technology company Hologic, released NovaSure V5, an innovative global endometrial ablation (GEA) device. This is the upgraded version of the pre-existing model, equipped with the ability to deliver radiofrequency energy to ablate the endometrial lining. Its SmartDepth technology offers a customised, more reliable, and accurate ablation to the patient. As medical technology continues to advance, there can be similar useful additions, boosting the endometrial ablation market growth.
Market Breakup by Type
Market Breakup by Indications
Market Breakup by End User
Market Breakup by Region- 7MM
The prevalence of gynaecological disorders has been continuously on the rise, accounting for around 4.5% of the overall global diseases. This can be attributed to a sedentary lifestyle, dietary changes, and indulgence into alcohol or tobacco. In addition, over 90% of the uterine cancers occur in the endometrial lining. Therefore, market for endometrial ablation is huge as it is applicable in a variety of domains. Owing to its successful results, when compared to oral therapy, hysterectomy or IUDs, the endometrial ablation market demand is on the rise.
North America has held the largest market share in the historic period. The presence of a proficient healthcare system that entails well-developed infrastructure for treatment and further research is one of the major factors for it. Yet, the endometrial ablation market share seems to shift towards the Asia Pacific region, as the government has started engaging in numerous women-centric health initiatives. For example, the Indian government has been quite proactive by setting outreach camps, national mobile medical units, and has launched schemes like the Janani Shishu Suraksha Karyakram (JSSK) and Surakshit Matritva Aashwasan (SUMAN), with an aim to spread awareness on women’s reproductive health. Such initiatives will fuel market growth in the forecast period.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Indications |
|
Breakup by End User |
|
Breakup by Region – 7MM |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Endometrial Ablation Market Overview
3.1 Endometrial Ablation Market Historical Value (2016-2022)
3.2 Endometrial Ablation Market Forecast Value (2023-2031)
4 Endometrial Ablation Market Landscape
4.1 Endometrial Ablation Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Endometrial Ablation Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indications
5 Endometrial Ablation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Endometrial Ablation Market Segmentation
6.1 Endometrial Ablation Market by Type
6.1.1 Market Overview
6.1.2 Devices
6.1.2.1 Radiofrequency Ablation
6.1.2.2 Cryoablation
6.1.2.3 Microwave Ablation
6.1.2.4 Hydrothermal Ablation
6.1.2.5 Thermal Balloon Ablation
6.1.2.6 Laser Ablation
6.1.2.7 Electrical Ablation
6.1.2.8 Others
6.1.3 Procedures
6.2 Endometrial Ablation Market by Indications
6.2.1 Market Overview
6.2.2 Abnormal Uterine Bleeding
6.2.3 Menorrhagia
6.2.4 Adenomyosis
6.2.5 Endometrial Hyperplasia
6.3 Endometrial Ablation Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Ambulatory Surgical Centres
6.3.5 Others
6.4 Endometrial Ablation Market by Region – 7MM
6.4.1 Market Overview
6.4.2 United States
6.4.3 EU-4 and the United Kingdom
6.4.4 Japan
7 United States Endometrial Ablation Market
7.1 U.S. Endometrial Ablation Market Historical Size (2016-2022)
7.2 U.S. Endometrial Ablation Market Forecast Size (2023-2031)
7.3 Market Size by Therapeutic Class
8 EU-5 and the United Kingdom Endometrial Ablation Market
8.1 EU-5 and the United Kingdom Endometrial Ablation Market Historical Size (2016-2022)
8.2 EU-5 and the United Kingdom Endometrial Ablation Market Forecast Size (2023-2031)
8.3 Market Size by Therapeutic Class
9 Japan Endometrial Ablation Market
9.1 Japan Endometrial Ablation Market Historical Size (2016-2022)
9.2 Japan Endometrial Ablation Market Forecast Size (2023-2031)
9.3 Market Size by Therapeutic Class
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Grants Analysis
11.1 Analysis by year
11.2 Analysis by Amount Awarded
11.3 Analysis by Issuing Authority
11.4 Analysis by Grant Application
11.5 Analysis by Funding Institute
11.6 Analysis by NIH Departments
11.7 Analysis by Recipient Organization
12 Funding Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Regulatory Framework
14.1 Regulatory Overview
14.1.1 US FDA
14.1.2 EU EMA
14.1.3 JAPAN PMDA
15 Supplier Landscape
15.1 AEGEA Medical, Inc.
15.1.1 Financial Analysis
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisition
15.1.5 Certifications
15.2 Boston Scientific Corporation
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisition
15.2.5 Certifications
15.3 CooperSurgical, Inc.
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisition
15.3.5 Certifications
15.4 Hologic, Inc.
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisition
15.4.5 Certifications
15.5 IDOMAN-MED
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisition
15.5.5 Certifications
15.6 Minerva Surgical, Inc.
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisition
15.6.5 Certifications
15.7 Olympus Corporation
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisition
15.7.5 Certifications
15.8 Omnitech Systems, Inc.
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisition
15.8.5 Certifications
15.9 Medtronic
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisition
15.9.5 Certifications
16 Endometrial Ablation Market - Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 3.4 billion in 2022, driven by the prevalence of gynaecological disorders like PCOS, menorrhagia across the globe.
The market is anticipated to grow at a CAGR of 6% during the forecast period of 2023-2031, likely to reach a market value of USD by 5.7 billion by 2031.
The rising incidence of gynaecological disorders PCOS, PCOD, and abnormal uterine bleeding, owing to lifestyle changes like sedentary routine, alcohol or tobacco consumption has been a key factor aiding the market growth.
North America accounted for a major share of the global market during the historical period. However, Asia Pacific is expected to witness fastest growth in the coming years owing to the proactive initiatives of the government. There has been an influx of technically advanced devices for accurate and efficient procedures. NovaSure V5 by Hologic is a recent addition.
Endometrial ablation can be divided into devices and procedures. Devices can be further categorised into radiofrequency ablation, cryoablation, microwave, hydrothermal, thermal balloon, laser, and electrical ablation, among others.
End users include hospitals, clinics, and ambulatory surgical centers, among others.
It includes abnormal uterine bleeding, menorrhagia, adenomyosis, and endometrial hyperplasia.
The major regions of the market include the United States, Japan, EU-4, and the United Kingdom.
Key players involved in the market are AEGEA Medical, Inc., Boston Scientific Corporation, CooperSurgical, Inc., Hologic, Inc., IDOMAN-MED, Minerva Surgical, Inc., Olympus Corporation, Omnitech Systems, Inc., and Medtronic.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.